Overview  >  Investor Relations  >  Corporate Governance  >  Board Committees & Charters

Pfizer Board Committees

The Audit Committee

Under the terms of its Charter, the Audit Committee meets at least 6 times a year, including periodic meetings held separately with management, the internal auditor, and the independent auditor. The Audit Committee represents and assists the Pfizer Board with the oversight of the integrity of the Company's financial statements and internal controls, the Company's compliance with legal and regulatory requirements, the independent auditor's qualifications and independence, the performance of the Company's internal audit function, and the independent auditor.

Board Member Independent Financial Expert  Position
Ronald Blaylock Yes Yes Member
Joseph J. Echevarria Yes Yes Member
Suzanne Nora Johnson Yes Yes Chair
James C. Smith Yes Yes Member
back to top

The Compensation Committee

Under the terms of its Charter, the Compensation Committee is directly responsible for establishing annual and long-term performance goals, and objectives for our elected officers.

Board Member Independent Position
Ronald E. Blaylock Yes Member
James Quincey Yes Member
James C. Smith Yes Chair
back to top

The Governance & Sustainability Committee

Under the terms of its Charter, the Governance & Sustainability Committee is responsible for considering and making recommendations to the Board concerning the appropriate size, function and needs of the Board.

Board Member Independent Position
Susan Desmond-Hellmann Yes Member
Joseph J. Echevarria Yes Chair
Helen H. Hobbs Yes Member
Dan R. Littman
Yes Member
back to top

The Executive Committee

The Executive Committee performs the duties and exercises the powers delegated to it by the Board of Directors.

Board Member Independent Position
Albert Bourla No Chair
Joseph J. Echevarria Yes Member
Scott Gottlieb Yes Member
Helen H. Hobbs Yes Member
Suzanne Nora Johnson Yes Member
Shantanu Narayen Yes Member
James C. Smith Yes Member
back to top

The Regulatory and Compliance Committee

Under the terms of its Charter, the Regulatory and Compliance Committee is primarily responsible for overseeing and reviewing the Company's healthcare law compliance programs and the status of compliance with laws, regulations, and internal procedures applicable to pharmaceutical sales and marketing activities.

Board Member Independent Position
Scott Gottlieb Yes Chair
Helen H. Hobbs Yes Member
Susan Hockfield Yes Member
Dan R. Littman Yes Member
Suzanne Nora Johnson Yes Member
back to top

The Science and Technology Committee

The Science and Technology Committee was established in 2003. Under the terms of its Charter, the Committee is responsible for periodically examining management's direction and investment in the Company's pharmaceutical Research & Development as well as in its technology initiatives.

The Committee may meet privately with independent consultants and be free to speak directly and independently with any members of management in discharging its responsibilities.

Board Member Independent Position
Susan Desmond-Hellmann Yes Member
Scott Gottlieb Yes Member
Helen H. Hobbs Yes Chair
Susan Hockfield Yes Member
Dan R. Littman Yes Member
back to top